Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Crystal C. Lipsey"'
Autor:
Crystal C. Lipsey, Adriana Harbuzariu, Robert W. Robey, Lyn M. Huff, Michael M. Gottesman, Ruben R. Gonzalez-Perez
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 11, p 3794 (2020)
Estrogen-receptor-negative breast cancer (BCER−) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER− progression, but its effects on patient survival and chemoresistance are not well understood. We hypothesize that lept
Externí odkaz:
https://doaj.org/article/807e54c44ed241e89a95c83e42814e60
Autor:
George Alyateem, Heidi M. Wade, Aaron A. Bickert, Crystal C. Lipsey, Priya Mondal, MacKinzie D. Smith, Rania M. Labib, Beverly A. Mock, Robert W. Robey, Michael M. Gottesman
Publikováno v:
Cancer Gene Therapy.
Autor:
Robert W. Robey, Christina M. Fitzsimmons, Wilfried M. Guiblet, William J.E. Frye, José M. González Dalmasy, Li Wang, Drake A. Russell, Lyn M. Huff, Andrew J. Perciaccante, Fatima Ali-Rahmani, Crystal C. Lipsey, Heidi M. Wade, Allison V. Mitchell, Siddhardha S. Maligireddy, David Terrero, Donna Butcher, Elijah F. Edmondson, Lisa M. Jenkins, Tatiana Nikitina, Victor B. Zhurkin, Amit K. Tiwari, Anthony D. Piscopio, Rheem A. Totah, Susan E. Bates, H. Efsun Arda, Michael M. Gottesman, Pedro J. Batista
Histone deacetylase inhibitors (HDACis) are part of a growing class of epigenetic therapies used for the treatment of cancer. While elevated levels of the efflux pump P-gp are associated within vitroresistance to romidepsin, this mechanism does not t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0eab6c73a6fa5f6f5baa893e9093b0da
https://doi.org/10.1101/2022.10.07.511310
https://doi.org/10.1101/2022.10.07.511310
Autor:
Robert W. Robey, Crystal C Lipsey, Lyn M. Huff, Michael M. Gottesman, Adriana Harbuzariu, Ruben R. Gonzalez-Perez
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 3794, p 3794 (2020)
International Journal of Molecular Sciences
Volume 21
Issue 11
International Journal of Molecular Sciences
Volume 21
Issue 11
Estrogen-receptor-negative breast cancer (BCER&minus
) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER&minus
progression, but its effects on patient survival and chemoresistance are not well understood. We hypo
) is mainly treated with chemotherapeutics. Leptin signaling can influence BCER&minus
progression, but its effects on patient survival and chemoresistance are not well understood. We hypo
Autor:
Lily Yang, Adriana Harbuzariu, Ruben R. Gonzalez-Perez, Ward Kirlin, Viola Lanier, Tia L. Harmon, Crystal C. Lipsey
Publikováno v:
World Journal of Clinical Oncology
Aim To develop a leptin peptide receptor antagonist linked to nanoparticles and determine its effect on viability of breast cancer cells. Methods The leptin antagonist, LPrA2, was coupled via EDAC [1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide] to ir
Autor:
Sha'Kayla Nunez, Viola Lanier, Ann Anu Kurian, Danielle Daley-Brown, Adriana Harbuzariu, Ruben R. Gonzalez, Tia L. Harmon, Crystal C. Lipsey
Publikováno v:
Molecular Cancer Therapeutics. 17:B046-B046
Obesity is pandemic and linked to higher incidence and poorer prognosis of several cancers, including pancreatic cancer (PC), triple-negative breast cancer (TNBC), and endometrial cancer type II (EmCa), which do not have targeted therapy. Commonly, p
Autor:
Gale W. Newman, Crystal C. Lipsey, Joy Milner, Johannes Waltenberger, Danielle Daley-Brown, Ruben R. Gonzalez-Perez, Viola Lanier, Leonard M. Anderson, Merle Leffers, Corey Gillespie, Nia Webb
Publikováno v:
The international journal of biochemistrycell biology. 79
Leptin increases vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), and Notch expression in cancer cells, and transphosphorylates VEGFR-2 in endothelial cells. However, the mechanisms involved in leptin's actions in endothelial cel
Publikováno v:
Cancer Research. 77:3544-3544
Background: Pancreatic cancer (PC) has consistently been the fourth cancer-related cause of death in United States for more than 10 years. Its dismal prognosis is due to the aggressive behavior, late detection, lack of reliable biomarkers and low res
Publikováno v:
Cancer Research. 77:3540-3540
Obesity is a global health issue that has been identified as a risk factor for several types of cancer. High levels of body fat and circulating leptin are typical identifiers of obesity in humans and animals. Leptin is a 16kD protein hormone which is
Autor:
Shakeyla Nunez, Viola Lanier, Pierre V. Candelaria, Cynthia Tchio, Adriana Harbuzariu, Ruben R. Gonzalez-Perez, Antonio Rampoldi, Danielle Daley-Brown, McKay Mullen, Tia L. Harmon, Courtney D. Dill, Crystal C. Lipsey, Ann Anu Kurian
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 26:B66-B66
Obesity incidence has reached alarming levels, particularly in minority populations: African American (AA) and Latinos. The risk of develop several cancers (i.e., breast, pancreatic and endometrial cancers) is strongly correlated to obesity. One of t